- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes.
February 28, 2020
Utilization of Stereotactic Ablative Body Radiation Therapy for Intact Renal Cell Carcinoma: Trends in Treatment and Predictors of Outcome.
February 28, 2020
Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population.
February 28, 2020
Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.
February 27, 2020
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions.
February 27, 2020
Pre-operative risk factors predicting missed diagnosis of renal vein tumor thrombus in renal cell carcinoma: a retrospective cohort study.
February 27, 2020
Cell cycle progression score has potential prognostic value for stage T1 renal cell carcinomas.
February 26, 2020
Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma.
February 26, 2020
A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus.
February 26, 2020
Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
February 25, 2020
Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma.
February 25, 2020
A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.
February 25, 2020
Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.
February 24, 2020
MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer.
February 24, 2020
A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma.
February 24, 2020
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study Approach.
February 21, 2020